University of Groningen Differential placental DNA methylation of VEGFA and LEP in small-for-gestational age fetuses with an abnormal cerebroplacental ratio Bekkering,

[1]  Stephen S. Roach.  Unbalanced , 2017 .

[2]  J. V. van Goudoever,et al.  Fetal Growth Restriction with Brain Sparing: Neurocognitive and Behavioral Outcomes at 12 Years of Age , 2017, The Journal of pediatrics.

[3]  A. David,et al.  Placenta-directed gene therapy for fetal growth restriction. , 2017, Seminars in fetal & neonatal medicine.

[4]  S. Zaina,et al.  Leptin and its Receptors in Human Placenta of Small, Adequate, and Large for Gestational Age Newborns , 2017, Hormone and Metabolic Research.

[5]  A. Bos,et al.  Correlation between Doppler flow patterns in growth‐restricted fetuses and neonatal circulation , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  A. Heazell,et al.  Placental PHLDA2 expression is increased in cases of fetal growth restriction following reduced fetal movements , 2016, BMC Medical Genetics.

[7]  Petra S Huppi,et al.  The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome , 2016, The Journal of physiology.

[8]  W. Petri,et al.  Leptin Regulation of Immune Responses. , 2016, Trends in molecular medicine.

[9]  J. Daniel,et al.  Methylation-dependent regulation of hypoxia inducible factor-1 alpha gene expression by the transcription factor Kaiso. , 2015, Biochimica et biophysica acta.

[10]  Timothy H. Ciesielski,et al.  Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth , 2015, BMC Pregnancy and Childbirth.

[11]  M. Fenech,et al.  Low-grade inflammation, diet composition and health: current research evidence and its translation , 2015, British Journal of Nutrition.

[12]  A. Zimna,et al.  Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies , 2015, BioMed research international.

[13]  B. Sibai,et al.  Hypoxia-Independent Upregulation of Placental Hypoxia Inducible Factor-1&agr; Gene Expression Contributes to the Pathogenesis of Preeclampsia , 2015, Hypertension.

[14]  C. Marsit,et al.  The Role of Placental 11-Beta Hydroxysteroid Dehydrogenase Type 1 and Type 2 Methylation on Gene Expression and Infant Birth Weight1 , 2015, Biology of reproduction.

[15]  G. Hitman,et al.  Novel DNA methylation profiles associated with key gene regulation and transcription pathways in blood and placenta of growth-restricted neonates , 2015, Epigenetics.

[16]  Simon James Tunster,et al.  The significance of elevated placental PHLDA2 in human growth restricted pregnancies. , 2014, Placenta.

[17]  E. Tartour,et al.  Control of the Immune Response by Pro-Angiogenic Factors , 2014, Front. Oncol..

[18]  B. Lester,et al.  Sex-specific associations between placental leptin promoter DNA methylation and infant neurobehavior , 2014, Psychoneuroendocrinology.

[19]  Gang Meng,et al.  Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  C. Marsit,et al.  Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors , 2013, Molecular and Cellular Endocrinology.

[21]  A. Hardikar,et al.  Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia , 2013, Clinical Epigenetics.

[22]  Albert Jeltsch,et al.  Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. , 2013, Journal of molecular biology.

[23]  J. Joó,et al.  Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[24]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[25]  D. Spandidos,et al.  DNA methylation in the human placenta and fetal growth (Review) , 2012, Molecular medicine reports.

[26]  M. Anselmino,et al.  Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter , 2011, Epigenetics.

[27]  Ö. Türeci,et al.  Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α , 2011, Oncogene.

[28]  J. Drzewińska,et al.  Identification and analysis of the promoter region of the human DHCR24 gene: involvement of DNA methylation and histone acetylation , 2011, Molecular Biology Reports.

[29]  Luigi Bouchard,et al.  Leptin Gene Epigenetic Adaptation to Impaired Glucose Metabolism During Pregnancy , 2010, Diabetes Care.

[30]  J. Kok,et al.  Behavioural problems at the age of eleven years in preterm-born children with or without fetal brain sparing: a prospective cohort study. , 2010, Early human development.

[31]  L. Lambertini,et al.  Differential expression of imprinted genes in normal and IUGR human placentas , 2009, Epigenetics.

[32]  F. Ciardo,et al.  Effects of prenatal betamethasone administration on leptin and adiponectin concentrations in maternal and fetal circulation. , 2008, American journal of obstetrics and gynecology.

[33]  R. Stöger.  In Vivo Methylation Patterns of the Leptin Promoter in Human and Mouse , 2006, Epigenetics.

[34]  R. Weksberg,et al.  Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. , 2006, Placenta.

[35]  T. Nomura,et al.  The role of leptin in the development of the cerebral cortex in mouse embryos. , 2006, Endocrinology.

[36]  M. Wabitsch,et al.  Leptin Gene Expression in Human Preadipocytes Is Switched on by Maturation-induced Demethylation of Distinct CpGs in Its Proximal Promoter* , 2002, The Journal of Biological Chemistry.

[37]  L. Woollett.  The origins and roles of cholesterol and fatty acids in the fetus , 2001, Current opinion in lipidology.

[38]  V. Castracane,et al.  Leptin in Pregnancy , 2000, Biology of reproduction.

[39]  N. Hoggard,et al.  Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. , 2000, Molecular human reproduction.

[40]  S. Varma,et al.  Co-transactivation of the 3' erythropoietin hypoxia inducible enhancer by the HIF-1 protein. , 1997, Blood cells, molecules & diseases.

[41]  K. Conrad,et al.  Expression of erythropoietin by the human placenta. , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  J. Wladimiroff,et al.  Severe intrauterine growth retardation; assessment of its origin from fetal arterial flow velocity waveforms. , 1986, European journal of obstetrics, gynecology, and reproductive biology.

[43]  R. Dammann,et al.  Epigenetic silencing of erythropoietin in human cancers. , 2011, Genes & cancer.

[44]  B. Paulweber,et al.  Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[45]  N. Hoggard,et al.  Placental leptin. , 2000, Reviews of reproduction.